These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21489910)

  • 21. Increased serum ferritin levels in active Behçet's disease.
    Odabas AR; Karakuzu A; Cetinkaya R; Selcuk Y; Keles S; Bilen H
    Int J Clin Pract; 2002 May; 56(4):310-1. PubMed ID: 12074217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of leptin level and Ob gene polymorphism in patients with Behcet's disease.
    Okudan N; Acar H; Gökbel H; Mevlitoğlu I; Sari F
    Arch Dermatol Res; 2006 Aug; 298(3):127-30. PubMed ID: 16786343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radial artery occlusion, a rare presentation of Behçet's disease.
    Gera C; Jose W; Malhotra N; Malhotra V; Dhanoa J
    J Assoc Physicians India; 2008 Aug; 56():643-4. PubMed ID: 19051714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Von Willebrand factor in Behçet's syndrome.
    Yazici H; Hekim N; Ozbakir F; Yurdakul S; Tüzün Y; Pazarli H; Müftüoğlu A
    J Rheumatol; 1987 Apr; 14(2):305-6. PubMed ID: 3496454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homocysteine: an activity marker in Behçet's disease?
    Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N
    J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Plasma exchange and acyclovir in Behçet's disease].
    Bonnet M; Ouzan D; Trepo C
    J Fr Ophtalmol; 1986; 9(1):15-22. PubMed ID: 3722720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythrocyte aggregation in Behçet's disease determined with the Sefam and Myrenne aggregometer. Lack of association with thrombosis and uveitis.
    Ricart JM; Vayá A; Todolí J; Santaolaria ML; Calvo J; Aznar J
    Clin Hemorheol Microcirc; 2005; 33(4):389-96. PubMed ID: 16317248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
    Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
    Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum mannose-binding lectin levels are decreased in behcet's disease and associated with disease severity.
    Inanc N; Mumcu G; Birtas E; Elbir Y; Yavuz S; Ergun T; Fresko I; Direskeneli H
    J Rheumatol; 2005 Feb; 32(2):287-91. PubMed ID: 15693089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulated activated platelets and increased platelet reactivity in patients with Behçet's disease.
    Akar S; Ozcan MA; Ateş H; Gürler O; Alacacioglu I; Ozsan GH; Akkoç N; Ozkan S; Demirkan F; Onen F
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):451-7. PubMed ID: 17000890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma endothelin-1 levels before and after vascular occlusive test in patients with Behçet's disease.
    Cimsit G; Karahan SC; Orem A; Vanizor B; Alpay K
    Australas J Dermatol; 2001 Aug; 42(3):221-2. PubMed ID: 11510468
    [No Abstract]   [Full Text] [Related]  

  • 32. Baseline and stimulated thyroid functions in Behçet's disease.
    Akdeniz S; Colak S; Tuzcu AK; Bahceci M; Harman M
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):878-9. PubMed ID: 16898920
    [No Abstract]   [Full Text] [Related]  

  • 33. Erythrocyte deformability does not seem to be altered in Behçet's disease.
    Simó M; Ricart JM; Santaolaria M; Ortí G; Vayá A
    Clin Hemorheol Microcirc; 2007; 36(1):83-8. PubMed ID: 17211064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Platelet function in patients with Behçet's disease--a study on platelet aggregability].
    Ohsone T; Yoshikawa K; Kogure M
    Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):188-93. PubMed ID: 3389261
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasma endothelin-1 concentrations in patients with Behçet's disease.
    Ural AU; Yalcin A; Beyan C; Isimer A; Bayhan H
    Scand J Rheumatol; 1994; 23(6):322-5. PubMed ID: 7801056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Blood coagulation and fibrinolytic system in Behçet's disease (author's transl)].
    Hamada T; Hosoi Y; Yoshimura R; Yamamoto S
    Nihon Hifuka Gakkai Zasshi; 1978 Sep; 88(10):615-25. PubMed ID: 309522
    [No Abstract]   [Full Text] [Related]  

  • 37. Hemostatic parameters in Behçet's disease: a reappraisal.
    Koşar A; Oztürk M; Haznedaroğlu IC; Karaaslan Y
    Rheumatol Int; 2002 May; 22(1):9-15. PubMed ID: 12120913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasminogen activator activity levels in patients with Behçet's syndrome.
    Mishima H; Masuda K; Shimada S; Toki N; Tsushima H; Gocho M
    Arch Ophthalmol; 1985 Jul; 103(7):935-6. PubMed ID: 4040357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum prolactin levels in Behçet's disease. Is there a relationship between Behcet's disease and prolactin as in other autoimmune diseases?
    Avci A; Avci D
    Acta Dermatovenerol Croat; 2013; 21(1):52-3. PubMed ID: 23683488
    [No Abstract]   [Full Text] [Related]  

  • 40. Abnormal polymorphonuclear leucocyte chemotaxis in Behçet's syndrome.
    James DW; Walker JR; Smith MJ
    Ann Rheum Dis; 1979 Jun; 38(3):219-21. PubMed ID: 485576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.